Skip to main content

Table 2 Sensitivity, specificity, PPV, NPV, and AUC of the model in the two cohorts

From: Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI

 

Sensitivity, %

Specificity, %

PPV, %

NPV, %

AUC (95% CI)

Cohort 1

92.50

82.50

74.60

95.10

0.936 (0.922–0.955)

Cohort 2

87.76

85.45

84.31

88.68

0.914 (0.914–0.955)